1
|
Enzinger PC and Mayer RJ: Esophageal
cancer. N Engl J Med. 349:2241–2252. 2003. View Article : Google Scholar : PubMed/NCBI
|
2
|
Xing D, Tan W and Lin D: Genetic
polymorphisms and susceptibility to esophageal cancer among Chinese
population (review). Oncol Rep. 10:1615–1623. 2003.PubMed/NCBI
|
3
|
Cho WC: OncomiRs: the discovery and
progress of microRNAs in cancers. Mol Cancer. 6:602007. View Article : Google Scholar : PubMed/NCBI
|
4
|
Matsushima K, Isomoto H, Kohno S and Nakao
K: MicroRNAs and esophageal squamous cell carcinoma. Digestion.
82:138–144. 2010. View Article : Google Scholar : PubMed/NCBI
|
5
|
Calin GA, Sevignani C, Dumitru CD, et al:
Human microRNA genes are frequently located at fragile sites and
genomic regions involved in cancers. Proc Natl Acad Sci USA.
101:2999–3004. 2004. View Article : Google Scholar : PubMed/NCBI
|
6
|
Yang M, Liu R, Sheng J, et al:
Differential expression profiles of microRNAs as potential
biomarkers for the early diagnosis of esophageal squamous cell
carcinoma. Oncol Rep. 29:169–176. 2013.PubMed/NCBI
|
7
|
Lin RJ, Xiao DW, Liao LD, et al:
MiR-142-3p as a potential prognostic biomarker for esophageal
squamous cell carcinoma. J Surg Oncol. 105:175–182. 2012.
View Article : Google Scholar : PubMed/NCBI
|
8
|
Xu X, Chen Z, Zhao X, et al: MicroRNA-25
promotes cell migration and invasion in esophageal squamous cell
carcinoma. Biochem Biophys Res Commun. 421:640–645. 2012.
View Article : Google Scholar : PubMed/NCBI
|
9
|
Guo Y, Chen Z, Zhang L, et al: Distinctive
microRNA profiles relating to patient survival in esophageal
squamous cell carcinoma. Cancer Res. 68:26–33. 2008. View Article : Google Scholar : PubMed/NCBI
|
10
|
Mathé EA, Nguyen GH, Bowman ED, et al:
MicroRNA expression in squamous cell carcinoma and adenocarcinoma
of the esophagus: associations with survival. Clin Cancer Res.
15:6192–6200. 2009.PubMed/NCBI
|
11
|
Song PI, Liang H, Fan JH, Wei WQ, Wang GQ
and Qiao YL: Long-term survival after esophagectomy for early
esophageal squamous cell carcinoma in Linxian, China. J Surg Oncol.
104:176–180. 2011. View Article : Google Scholar : PubMed/NCBI
|
12
|
Sun X, Chen W, Chen Z, Wen D, Zhao D and
He Y: Population-based case-control study on risk factors for
esophageal cancer in five high-risk areas in China. Asian Pac J
Cancer Prev. 11:1631–1636. 2010.PubMed/NCBI
|
13
|
Hu YC, Lam KY, Law S, Wong J and
Srivastava G: Identification of differentially expressed genes in
esophageal squamous cell carcinoma (ESCC) by cDNA expression array:
overexpression of Fra-1, Neogenin, Id-1, and CDC25B genes in ESCC.
Clin Cancer Res. 7:2213–2221. 2001.PubMed/NCBI
|
14
|
Li Y, Chen L, Nie CJ, Zeng TT, Liu H, Mao
X, Qin Y, Zhu YH, Fu L and Guan XY: Downregulation of RBMS3 is
associated with poor prognosis in esophageal squamous cell
carcinoma. Cancer Res. 19:6106–6115. 2011. View Article : Google Scholar : PubMed/NCBI
|
15
|
Rosenfeld N, Aharonov R, Meiri E, et al:
MicroRNAs accurately identify cancer tissue origin. Nat Biotechnol.
26:462–469. 2008. View
Article : Google Scholar : PubMed/NCBI
|
16
|
Feber A, Xi L, Luketich JD, Pennathur A,
et al: MicroRNA expression profiles of esophageal cancer. J Thorac
Cardiovasc Surg. 135:255–260. 2008. View Article : Google Scholar
|
17
|
Zhang C, Wang C, Chen X, et al: Expression
profile of microRNAs in serum: a fingerprint for esophageal
squamous cell carcinoma. Clin Chem. 56:1871–1879. 2010. View Article : Google Scholar : PubMed/NCBI
|